v3.26.1
Condensed Consolidated Statements of Shareholders’ Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income
Accumulated Deficit
Noncontrolling Interests
Beginning balance (in shares) at Mar. 31, 2025   695,938,323        
Beginning balance at Mar. 31, 2025 $ 5,187,198 $ 0 $ 4,562,107 $ 9,438 $ 116,060 $ 499,593
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of the Company’s common shares in connection with equity incentive plans, net of forfeitures, and tax withholding payments (in shares)   6,560,959        
Issuance of the Company’s common shares in connection with equity incentive plans, net of forfeitures, and tax withholding payments 16,912   16,912      
Exercise and vesting of subsidiary share awards 3,613   2,325     1,288
Cash contributions to majority-owned subsidiaries 0   (290)     290
Repurchase of the Company's common shares (in shares)   (20,269,450)        
Repurchase of the Company’s common shares (208,293)       (208,293)  
Share-based compensation 82,178   63,031     19,147
Unrealized (losses) gains on available-for-sale securities 470     470    
Foreign currency translation adjustment 7,739     7,229   510
Net loss (273,911)       (223,355) (50,556)
Ending balance (in shares) at Jun. 30, 2025   682,229,832        
Ending balance at Jun. 30, 2025 $ 4,815,906 $ 0 4,644,085 17,137 (315,588) 470,272
Beginning balance (in shares) at Mar. 31, 2026 720,352,386 720,352,386        
Beginning balance at Mar. 31, 2026 $ 5,292,412 $ 0 5,024,826 4,358 (501,814) 765,042
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of the Company’s common shares in connection with equity incentive plans, net of forfeitures, and tax withholding payments (in shares)   9,208,139        
Issuance of the Company’s common shares in connection with equity incentive plans, net of forfeitures, and tax withholding payments 24,596   24,596      
Exercise and vesting of subsidiary share awards 23,634   13,470     10,164
Issuance of subsidiary shares to the Company and cash contributions to majority-owned subsidiaries 0   (1,265)     1,265
Repurchase of the Company's common shares (in shares)   (6,892,463)        
Repurchase of the Company’s common shares (208,703)       (208,703)  
Issuance of the Company’s common shares under employee stock purchase plan 635   635      
Share-based compensation 83,342   68,664     14,678
Unrealized (losses) gains on available-for-sale securities (2,987)     (2,987)    
Foreign currency translation adjustment (454)     (670)   216
Net loss $ (290,606)       (189,837) (100,769)
Ending balance (in shares) at Jun. 30, 2026 722,668,062 722,668,062        
Ending balance at Jun. 30, 2026 $ 4,921,869 $ 0 $ 5,130,926 $ 701 $ (900,354) $ 690,596